Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Charles Gasparino Tweets “Elon Musk Told Investment Bankers Recently That His Intention Was Still To Buy Twitter Even As He Was Headed To Court Indicating His About Face On The Purchase Was A Ploy To Renegotiate Terms, A Person With Direct Knowledge Te…

(1) Charles Gasparino on Twitter: "Scoop (2/2) the legal drama and offer to buy at agreed upon price ($54.20 a share) when it became clear he would lose in court and the discovery would be damaging to his brand and @Tesla, this person says. More at 130pm @TeamCavuto" / Twitter
byBenzinga Newsdesk
October 5, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

(1) Charles Gasparino on Twitter: “Scoop (2/2) the legal drama and offer to buy at agreed upon price ($54.20 a share) when it became clear he would lose in court and the discovery would be damaging to his brand and @Tesla, this person says. More at 130pm @TeamCavuto” / Twitter

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

BioMarin Announced Stable and Durable Annualized Bleed Control for ROCTAVIAN in Largest Phase 3 Gene Therapy Study in Adults with Severe Hemophilia A; Said 92% of Patients off Prophylaxis at the End of Year 3

By Charles Gross
Today, 11:45 PM
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced positive results from more than three years of follow up from its ongoing global Phase 3 GENEr8-1 study of ROCTAVIANTM (valoctocogene roxaparvovec), an investigational one-time gene therapy for the treatment of adults with severe hemophilia A.

BMRN